TransMedics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
ANDOVER, Mass., Dec. 18, 2023 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will present at the upcoming 42nd Annual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 8, 2024, at 3:00 p.m. Pacific Standard Time / 6:00 p.m. Eastern Standard Time.
Related news for (TMDX)
- Berman Tabacco Announces Investigation of TransMedics Group, Inc. (TMDX) Concerning Claims by Scorpion Capital and Its FDA Citizen Petition
- Berman Tabacco Announces Investigation of TransMedics Group, Inc. (TMDX) Concerning Claims by Scorpion Capital
- Biotech Headliners
- New Innovation-Themed Whitepaper to Debut at the February 1st Emerald Groundhog Day Investment Forum
- Investment Opportunities in the Innovation Economy Headline the 2024 Emerald Groundhog Day Investment Forum